Moderna seeks urgent approval to vaccinate very young children

Biotech company Moderna announced on Wednesday that it is applying to the Food and Drug Administration (FDA) for emergency use authorization to allow the administration of coronavirus vaccines to very young children, those aged between six months and six years inclusive.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button